Correction to Lancet Oncol 2015; 16: e227. Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging
- PMID: 26149883
- DOI: 10.1016/S1470-2045(15)00072-8
Correction to Lancet Oncol 2015; 16: e227. Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging
Erratum for
-
Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging.Lancet Oncol. 2015 May;16(5):e226-33. doi: 10.1016/S1470-2045(15)70075-6. Lancet Oncol. 2015. PMID: 25943067 Review.
Publication types
LinkOut - more resources
Full Text Sources
